Hepatocyte growth factor and chronic hepatitis C

Revista Espanola de Enfermedades Digestivas

Volumn 102, Issue 6, 2010, Pages 365-371

  Marin Serrano E ^a   Rodriguez Ramos C ^a   Diaz Garcia F ^a   Martin Herrera L ^a   Fernandez Gutierrezdel Alamo C ^a   Giron Gonzalez J A ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Chronic hepatitis C; Hepatocyte growth factor (HGF); Liver fibrosis

Indexed keywords

ALBUMIN; ALPHA INTERFERON; ALPHA2A INTERFERON; ALPHA2B INTERFERON; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; INTERFERON; PEGINTERFERON ALPHA; PROTHROMBIN; RIBAVIRIN; SCATTER FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; MALE; PROTEIN BLOOD LEVEL; SCORING SYSTEM; THROMBOCYTE COUNT; VIRUS LOAD;

EID: 77957948638     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082010000600004     Document Type: Article

References (31)

1. Valiente N, D'Andrea A, Corta S, Lechner F, Klenerman P, Nuti S, et al. Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C. Immunol Rev 2000; 174: 77-89.
2. Winwood PJ, Arthur MJ. Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Semin Liver Dis 1993; 13: 50-59.
3. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-218.
4. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol 2003; 38 (Supl. 1): S38-S53.
5. Marín Gabriel JC, Solís Herruzo JA. Predicting liver fibrosis with non-invasive tests-a hope for the future. Rev Esp Enferm Dig 2008; 100: 605-610.
6. Fausto N. Liver regeneration. J Hepatol 2000; 32: 19-31.
7. Zimmermann A. Liver regeneration. Nephrol Dial Transplant 2004; 19 (Supl. 4): iv6-iv10.
8. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-832.
9. Xue F, Takahara T, Yata Y, Kuwabara Y, Shinno E, Nonome K, et al. Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy. Gut 2003; 52: 694-700.
10. Yamagami H, Moriyama M, Tanaka N. Detection of serum and intrahepatic human hepatocyte growth factor in patients with type C liver diseases. Intervirology 2001; 44: 36-42.
11. Yamagami H, Moriyama M, Matsumura H, Aoki H, Shimizu T, Saito T, et al. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases. Cancer 2002; 95: 824-834.
12. Okano J, Shiota G, Kawasaki H. Expression of hepatocyte growth factor (HGF) and HGF receptor (c-met) proteins in liver diseases: an immunohistochemical study. Liver 1999; 19: 151-159.
13. Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 1995; 21: 106-112.
14. Bilezikci B, Haberal AN, Demirhan B. Hepatocyte growth factor in patients with three different stages of chronic liver disease including hepatocellular carcinoma, cirrhosis and chronic hepatitis: an immunohistochemical study. Can J Gastroenterol 2001; 15: 159-165.
15. Anatol P, Robert F, Danuta P. Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C. World J Gastroenterol 2005; 11: 1854-1858.
16. McHutchison PG, Poynard T. Combination therapy with interferon plus ribavirin for initial treatment of chronic hepatitis C. Semin Liver Dis 1999; 19: 57-65.
17. Bisceglie DI, Hoofnagle JH. Optimal therapy of hepatitis C. Hepatology 2002; 36: S121-S127.
18. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
19. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
20. Forns X, Ampurdanès S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36: 986-992.
21. Wai CT, Greeson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526.
22. Stuart KA, Riordan SM, Lidder S, Crostella L, Willians R, Skouteris GG. Hepatocyte growth factor/scatter factor induced intracellular signalling. Int J Exp Pathol 2000; 81: 17-30.
23. Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 1985; 82: 8681-8685.
24. Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusión on liver fibrosis/cirrhosis. Hepatology 1997; 26: 81-89.
25. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 1996; 24: 636-642.
26. Sato M, Kakubari M, Kawamura M, Sugimoto J, Matsumoto K, Ishii T. The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamide. Biochem Pharmacol 2000; 59: 681-690.
27. Osaki I, Zhao G, Mizuta T, Ogawa Y, Hara T, Kajihara S, et al. Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line. J Hepatol 2002; 36: 169-178.
28. Chang XM, Chang Y, Jia A. Effects of interferon alpha on expression of hepatic stellate cell and transforming growth factor-β1 and α-smooth muscle actin in rats with hepatic fibrosis. World J Gastroenterol 2005; 11: 2634-2636.
29. Shiratori Y, Imazeki F, Moriyama M, Yano M, Arakawa Y, Yokosuka O, et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med 2000; 132: 512-524.
30. Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002; 122: 1303-1313.
31. Moriyama M, Matsumura H, Watanabe A, Oshiro S, Aoki H, Shimizo T, et al. Evaluation of serum concentrations of human hepatocyte growth factor during interferon therapy for chronic hepatitis C. Intervirology 2005; 48: 223-229.